South Korea Blastic Plasmacytoid Dendritic Cell Neoplasm (BPDCN)...

added blog Home

2026-10-09 12:16:39 -

South Korea Blastic Plasmacytoid Dendritic Cell Neoplasm (BPDCN) Market Growth and Treatment Developments

South Korea Blastic Plasmacytoid Dendritic Cell Neoplasm (BPDCN) Market Overview Valued at USD 42.88 million in 2024, the South Korea blastic plasmacytoid dendritic cell neoplasm (BPDCN) market is projected to reach USD 45.88 million in 2025 and USD 85.78 million by 2034, growing at a CAGR of 7.20% during the forecast period 2025–2034. BPDCN is a rare and aggressive hematologic cancer...

0 Comments 0 Shares 7 Views 0 Reviews